Biomarkers for cancer-associated fibroblasts
Abstract Cancer-associated fibroblasts (CAFs) are the key component of tumor stromal. High heterogeneity of CAFs reflects in their origin, phenotype and function. Biological function which can be suggested by biomarkers of distinct CAF subgroups may be different, even opposite, just like water and f...
Main Authors: | Chencheng Han, Tongyan Liu, Rong Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-020-00245-w |
Similar Items
-
What is new in cancer-associated fibroblast biomarkers?
by: Zehua Zhao, et al.
Published: (2023-05-01) -
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
by: Kévin Louault, et al.
Published: (2020-10-01) -
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
by: Dengdi Hu, et al.
Published: (2022-05-01) -
The cellular triumvirate: fibroblasts entangled in the crosstalk between cancer cells and immune cells
by: Adel Fergatova, et al.
Published: (2024-01-01) -
Identification of cancer-associated fibroblasts subtypes in prostate cancer
by: Jiahua Pan, et al.
Published: (2023-03-01)